Atai Life Sciences Ownership 2024 | Who Owns Atai Life Sciences Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

7.51%

Insider Ownership

10.01%

Retail Ownership

82.48%

Institutional Holders

88.00

Atai Life Sciences Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WALLEYE CAPITAL LLC1.74%0.01%2,762,7602,660,3922598.85%3,674,471Jun 30, 2024
MORGAN STANLEY1.71%0.00%2,718,84250,8991.91%3,616,061Jun 30, 2024
BLACKROCK INC.0.82%-1,306,903-94,533-6.75%1,738,181Jun 30, 2024
BROWN UNIVERSITY0.45%0.36%718,500--955,605Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.45%0.00%717,131316,14678.84%953,784Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.41%0.00%648,186-1,568,334-70.76%862,087Jun 30, 2024
VANGUARD GROUP INC0.26%-411,484-2,292-0.55%547,274Jun 30, 2024
FRANKLIN RESOURCES INC0.22%0.00%356,357--473,955Jun 30, 2024
BARCLAYS PLC0.15%0.00%245,717--327,000Jun 30, 2024
ADVISORSHARES INVESTMENTS LLC0.13%0.05%200,83118,64310.23%271,122Jun 30, 2024
GOLDMAN SACHS GROUP INC0.12%-196,959-22,359-10.19%261,955Jun 30, 2024
HYPERION CAPITAL ADVISORS LP0.11%0.11%168,416--223,993Jun 30, 2024
BANK OF AMERICA CORP /DE/0.08%-125,54443,00352.10%166,974Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.07%-117,226--155,910Jun 30, 2024
STATE STREET CORP0.05%-81,060--107,810,000Jun 30, 2024
SEAVIEW INVESTMENT MANAGERS LLC0.03%0.02%49,922--66,396Jun 30, 2024
ROYAL BANK OF CANADA0.03%-49,724-2,000-3.87%65,000Jun 30, 2024
SG AMERICAS SECURITIES, LLC0.03%0.00%48,93748,937100.00%65,000Jun 30, 2024
CERITY PARTNERS LLC0.03%0.00%47,965-3,557-6.90%63,794Jun 30, 2024
VIRTU FINANCIAL LLC0.03%0.00%46,95346,953100.00%62,000Jun 30, 2024

Atai Life Sciences's largest institutional shareholder is WALLEYE CAPITAL LLC, holding 1.74% of the company's total share outstanding, currently valued at $3.67M. The top 10 institutional shareholders own together 6.35% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BROWN UNIVERSITY0.45%0.36%718,500--955,605Jun 30, 2024
HYPERION CAPITAL ADVISORS LP0.11%0.11%168,416--223,993Jun 30, 2024
OBJECTIVITY SQUARED, LLC0.03%0.06%45,2099482.14%74,143Jun 30, 2024
ADVISORSHARES INVESTMENTS LLC0.13%0.05%200,83118,64310.23%271,122Jun 30, 2024
AUDENT GLOBAL ASSET MANAGEMENT, LLC0.01%0.02%16,837--22,393Jun 30, 2024
SEAVIEW INVESTMENT MANAGERS LLC0.03%0.02%49,922--66,396Jun 30, 2024
WALLEYE CAPITAL LLC1.74%0.01%2,762,7602,660,3922598.85%3,674,471Jun 30, 2024
MOLONEY SECURITIES ASSET MANAGEMENT, LLC0.02%0.01%30,00030,000100.00%39,900Jun 30, 2024
RESOLUTE ADVISORS LLC0.01%0.01%16,777--22,313Jun 30, 2024
HUNTER PERKINS CAPITAL MANAGEMENT, LLC0.01%0.00%17,241-2,000-10.39%23,000Jun 30, 2024
GOULD CAPITAL, LLC0.00%0.00%5,000--6,650Jun 30, 2024
DETALUS ADVISORS, LLC0.01%0.00%10,000--13,300Jun 30, 2024
VIRTU FINANCIAL LLC0.03%0.00%46,95346,953100.00%62,000Jun 30, 2024
PALE FIRE CAPITAL SE0.02%0.00%24,78424,784100.00%32,963Jun 30, 2024
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD.0.01%0.00%19,666-12,233-38.35%26,156Jun 30, 2024
XML FINANCIAL, LLC0.02%0.00%27,457--36,518Jun 30, 2024
CRA FINANCIAL SERVICES, LLC0.01%0.00%12,903--17,161Jun 30, 2024
M HOLDINGS SECURITIES, INC.0.01%0.00%18,16018,160100.00%24,000Jun 30, 2024
WEDMONT PRIVATE CAPITAL0.02%0.00%25,00025,000100.00%38,500Jun 30, 2024
VERDENCE CAPITAL ADVISORS LLC0.01%0.00%19,109--25,415Jun 30, 2024

The largest Atai Life Sciences shareholder by % of total assets is BROWN UNIVERSITY. The company owns 718.50K shares of Atai Life Sciences (ATAI), representing 0.36% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WALLEYE CAPITAL LLC1.74%0.01%2,762,7602,660,3922598.85%3,674,471Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.45%0.00%717,131316,14678.84%953,784Jun 30, 2024
MORGAN STANLEY1.71%0.00%2,718,84250,8991.91%3,616,061Jun 30, 2024
SG AMERICAS SECURITIES, LLC0.03%0.00%48,93748,937100.00%65,000Jun 30, 2024
VIRTU FINANCIAL LLC0.03%0.00%46,95346,953100.00%62,000Jun 30, 2024
BANK OF AMERICA CORP /DE/0.08%-125,54443,00352.10%166,974Jun 30, 2024
MOLONEY SECURITIES ASSET MANAGEMENT, LLC0.02%0.01%30,00030,000100.00%39,900Jun 30, 2024
WEDMONT PRIVATE CAPITAL0.02%0.00%25,00025,000100.00%38,500Jun 30, 2024
CRESSET ASSET MANAGEMENT, LLC0.02%0.00%36,32424,793215.01%48,311Jun 30, 2024
PALE FIRE CAPITAL SE0.02%0.00%24,78424,784100.00%32,963Jun 30, 2024
ADVISORSHARES INVESTMENTS LLC0.13%0.05%200,83118,64310.23%271,122Jun 30, 2024
M HOLDINGS SECURITIES, INC.0.01%0.00%18,16018,160100.00%24,000Jun 30, 2024
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.0.01%0.00%13,67413,674100.00%18,000Jun 30, 2024
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.0.01%-12,94612,946100.00%17,218Jun 30, 2024
KESTRA ADVISORY SERVICES, LLC0.01%0.00%12,38212,382100.00%16,468Jun 30, 2024
CI PRIVATE WEALTH, LLC0.02%0.00%30,50011,81563.23%40,565Jun 30, 2024
SQUAREPOINT OPS LLC0.01%0.00%23,76811,31090.78%31,611Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.01%0.00%17,2258,55598.67%22,910Jun 30, 2024
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.0.00%-4,9984,998100.00%6,597Jun 30, 2024
SIMPLEX TRADING, LLC0.00%-3,7943,794100.00%5,000Jun 30, 2024

As of Jun 30 2024, Atai Life Sciences's largest institutional buyer is WALLEYE CAPITAL LLC. The company purchased 2.66M stocks of ATAI, valued at $3.67M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MILLENNIUM MANAGEMENT LLC0.41%0.00%648,186-1,568,334-70.76%862,087Jun 30, 2024
MARSHALL WACE, LLP----793,839-100.00%-Jun 30, 2024
TEJARA CAPITAL LTD----260,215-100.00%-Jun 30, 2024
XTX TOPCO LTD----184,612-100.00%-Jun 30, 2024
BANK OF MONTREAL /CAN/----140,692-100.00%-Jun 30, 2024
BLACKROCK INC.0.82%-1,306,903-94,533-6.75%1,738,181Jun 30, 2024
QUATTRO FINANCIAL ADVISORS LLC----70,976-100.00%-Jun 30, 2024
TWO SIGMA SECURITIES, LLC----55,540-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----50,556-100.00%-Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----36,288-100.00%-Jun 30, 2024
AMERICAN CENTURY COMPANIES INC0.01%-10,541-36,087-77.39%14,020Jun 30, 2024
KINGSWOOD WEALTH ADVISORS, LLC----30,000-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC0.12%-196,959-22,359-10.19%261,955Jun 30, 2024
JPMORGAN CHASE & CO0.01%-17,924-18,752-51.13%23,839Jun 30, 2024
GSA CAPITAL PARTNERS LLP----14,431-100.00%-Jun 30, 2024
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD.0.01%0.00%19,666-12,233-38.35%26,156Jun 30, 2024
CIBC PRIVATE WEALTH GROUP, LLC----7,972-100.00%-Jun 30, 2024
CERITY PARTNERS LLC0.03%0.00%47,965-3,557-6.90%63,794Jun 30, 2024
VANGUARD GROUP INC0.26%-411,484-2,292-0.55%547,274Jun 30, 2024
HUNTER PERKINS CAPITAL MANAGEMENT, LLC0.01%0.00%17,241-2,000-10.39%23,000Jun 30, 2024

As of Jun 30 2024, Atai Life Sciences's biggest institutional seller is MILLENNIUM MANAGEMENT LLC. The company sold -1.57M shares of ATAI, valued at $862.09K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SG AMERICAS SECURITIES, LLC0.03%0.00%48,93748,937100.00%65,000Jun 30, 2024
MOLONEY SECURITIES ASSET MANAGEMENT, LLC0.02%0.01%30,00030,000100.00%39,900Jun 30, 2024
WEDMONT PRIVATE CAPITAL0.02%0.00%25,00025,000100.00%38,500Jun 30, 2024
PALE FIRE CAPITAL SE0.02%0.00%24,78424,784100.00%32,963Jun 30, 2024
M HOLDINGS SECURITIES, INC.0.01%0.00%18,16018,160100.00%24,000Jun 30, 2024
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.0.01%0.00%13,67413,674100.00%18,000Jun 30, 2024
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.0.01%-12,94612,946100.00%17,218Jun 30, 2024
KESTRA ADVISORY SERVICES, LLC0.01%0.00%12,38212,382100.00%16,468Jun 30, 2024
LEGEND FINANCIAL ADVISORS, INC.0.00%0.00%233233100.00%310Jun 30, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC0.00%0.00%200200100.00%266Jun 30, 2024

Atai Life Sciences's largest new institutional shareholder by number of shares is SG AMERICAS SECURITIES, LLC, purchased 48.94K shares, valued at $65.00K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MARSHALL WACE, LLP----793,839-100.00%-Jun 30, 2024
TEJARA CAPITAL LTD----260,215-100.00%-Jun 30, 2024
XTX TOPCO LTD----184,612-100.00%-Jun 30, 2024
BANK OF MONTREAL /CAN/----140,692-100.00%-Jun 30, 2024
QUATTRO FINANCIAL ADVISORS LLC----70,976-100.00%-Jun 30, 2024
TWO SIGMA SECURITIES, LLC----55,540-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----50,556-100.00%-Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----36,288-100.00%-Jun 30, 2024
KINGSWOOD WEALTH ADVISORS, LLC----30,000-100.00%-Jun 30, 2024
GSA CAPITAL PARTNERS LLP----14,431-100.00%-Jun 30, 2024
CIBC PRIVATE WEALTH GROUP, LLC----7,972-100.00%-Jun 30, 2024
CORNERSTONE PLANNING GROUP LLC----400-100.00%-Jun 30, 2024
CWM, LLC----350-100.00%-Jun 30, 2024

Atai Life Sciences's largest sold out institutional shareholder by shares sold is MARSHALL WACE, LLP, sold -0.79M shares, valued at -, as of undefined.

Atai Life Sciences Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
NEXPOINT FUNDS I0.02%90,000--Dec 31, 2023
Nushares ETF Trust0.02%161,332--Jan 31, 2024
ALPS ETF Trust0.01%110,053--Feb 29, 2024
VANGUARD WORLD FUND0.00%414,592-19,752-4.55%Feb 29, 2024
ETF Series Solutions0.00%27,893--Jan 31, 2024
Direxion Shares ETF Trust0.00%173,337--Jan 31, 2024
AMERICAN CENTURY ETF TRUST0.00%22,644-25,125-52.60%Feb 29, 2024
NORTHERN FUNDS0.00%24,479--Mar 28, 2024
Listed Funds Trust0.00%690--Mar 31, 2024
iSHARES TRUST0.00%869,209--Mar 31, 2024
VANGUARD QUANTITATIVE FUNDS0.00%148--Mar 31, 2024
Invesco Exchange-Traded Fund Trust II0.00%4,4051,45849.47%Feb 29, 2024

Atai Life Sciences's largest mutual fund holder by % of total assets is "NEXPOINT FUNDS I", owning 90.00K shares, compromising 0.02% of its total assets.

Atai Life Sciences Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2488-2.22%
31 Mar, 24903.45%
31 Dec, 2387-9.38%
30 Sep, 2396-2.04%
30 Jun, 2398-7.55%
31 Mar, 23106-13.11%
31 Dec, 2212223.23%
30 Sep, 22993.13%
30 Jun, 22967.87%
31 Mar, 2289-
31 Dec, 218945.90%
30 Sep, 216141.86%
30 Jun, 2143-

As of 30 Jun 24, 88 institutions are holding Atai Life Sciences's shares, representing a decrease of -2.22% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2411,929,942-3.40%
31 Mar, 2412,349,507-6.74%
31 Dec, 2313,241,539-8.77%
30 Sep, 2314,514,979-4.19%
30 Jun, 2315,150,149-11.37%
31 Mar, 2317,094,050-31.42%
31 Dec, 2224,925,721-5.94%
30 Sep, 2226,499,80122.74%
30 Jun, 2221,589,63739.23%
31 Mar, 2215,506,0118.83%
31 Dec, 2114,247,89524.08%
30 Sep, 2111,482,855-1.31%
30 Jun, 2111,635,398-

Atai Life Sciences (ATAI) has 11.93M shares outstanding as of 30 Jun 24, down -3.40% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 247.51%12.42%
31 Mar, 247.77%10.76%
31 Dec, 238.50%9.79%
30 Sep, 239.32%9.85%
30 Jun, 239.72%8.08%
31 Mar, 2310.97%4.45%
31 Dec, 2215.71%5.49%
30 Sep, 2216.92%8.61%
30 Jun, 2214.02%13.75%
31 Mar, 2210.10%9.51%
31 Dec, 2110.30%17.85%
30 Sep, 217.60%9.82%
30 Jun, 218.80%-

As of 30 Jun 24, Atai Life Sciences is held by 7.51% institutional shareholders, representing a 12.42% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2429-
31 Mar, 2429-17.14%
31 Dec, 233529.63%
30 Sep, 2327-25.00%
30 Jun, 2336-23.40%
31 Mar, 2347-35.62%
31 Dec, 227365.91%
30 Sep, 2244-27.87%
30 Jun, 226124.49%
31 Mar, 2249-26.87%
31 Dec, 2167123.33%
30 Sep, 2130-30.23%
30 Jun, 2143-

29 institutional shareholders have increased their position in ATAI stock as of 30 Jun 24 compared to 29 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2415-25.00%
31 Mar, 2420-
31 Dec, 2320-25.93%
30 Sep, 232712.50%
30 Jun, 2324-11.11%
31 Mar, 232768.75%
31 Dec, 2216-5.88%
30 Sep, 221730.77%
30 Jun, 2213-38.10%
31 Mar, 2221162.50%
31 Dec, 218-38.46%
30 Sep, 2113-
30 Jun, 21--

15 institutional shareholders have reduced their position in ATAI stock as of 30 Jun 24 compared to 20 in the previous quarter (a -25.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2488-2.22%11,929,942-3.40%7.51%12.42%29-15-25.00%
31 Mar, 24903.45%12,349,507-6.74%7.77%10.76%29-17.14%20-
31 Dec, 2387-9.38%13,241,539-8.77%8.50%9.79%3529.63%20-25.93%
30 Sep, 2396-2.04%14,514,979-4.19%9.32%9.85%27-25.00%2712.50%
30 Jun, 2398-7.55%15,150,149-11.37%9.72%8.08%36-23.40%24-11.11%
31 Mar, 23106-13.11%17,094,050-31.42%10.97%4.45%47-35.62%2768.75%
31 Dec, 2212223.23%24,925,721-5.94%15.71%5.49%7365.91%16-5.88%
30 Sep, 22993.13%26,499,80122.74%16.92%8.61%44-27.87%1730.77%
30 Jun, 22967.87%21,589,63739.23%14.02%13.75%6124.49%13-38.10%
31 Mar, 2289-15,506,0118.83%10.10%9.51%49-26.87%21162.50%
31 Dec, 218945.90%14,247,89524.08%10.30%17.85%67123.33%8-38.46%
30 Sep, 216141.86%11,482,855-1.31%7.60%9.82%30-30.23%13-
30 Jun, 2143-11,635,398-8.80%-43---

Atai Life Sciences Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 20, 2024Brand Florianofficer See RemarksS-SaleSell151,303$1.92$290.50K328,697
Apr 04, 2024Johnson Anne Nagengastofficer Chief Financial OfficerS-SaleSell27,410$1.85$50.71K73,590
Apr 04, 2024Rao Srinivasofficer See RemarksS-SaleSell61,640$1.85$114.03K113,360
Apr 04, 2024Kirpekar Sahilofficer Chief Business OfficerS-SaleSell35,801$1.85$66.23K64,199

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 20, 2024Brand Florianofficer See RemarksS-SaleSell151,303$1.92$290.50K328,697
Apr 17, 2024Apeiron Investment Group Ltd.10 percent owner-J-OtherSell147,950---
Apr 04, 2024Johnson Anne Nagengastofficer Chief Financial OfficerS-SaleSell27,410$1.85$50.71K73,590
Apr 04, 2024Rao Srinivasofficer See RemarksS-SaleSell61,640$1.85$114.03K113,360
Apr 04, 2024Kirpekar Sahilofficer Chief Business OfficerS-SaleSell35,801$1.85$66.23K64,199
Mar 15, 2024Johnson Anne Nagengastofficer Chief Financial OfficerM-ExemptSell100,000--100,000
Mar 15, 2024Kirpekar Sahilofficer Chief Business OfficerM-ExemptSell100,000--100,000

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 14, 2024Auerbach Michaeldirector-A-AwardBuy103,000$1.34$138.02K103,000
Jun 14, 2024Angermayer Christiandirector, 10 percent owner A-AwardBuy103,000$1.34$138.02K103,000
Jun 14, 2024Braunstein Scottdirector-A-AwardBuy206,000$1.34$276.04K206,000
Jun 14, 2024Smiley Andrea Heslindirector-A-AwardBuy103,000$1.34$138.02K103,000
Jun 14, 2024Fischer Laurentdirector-A-AwardBuy206,000$1.34$276.04K206,000
Jun 14, 2024Kalali Amir Hdirector-A-AwardBuy103,000$1.34$138.02K103,000
Jun 14, 2024JOHNSON SABRINA MARTUCCIdirector-A-AwardBuy103,000$1.34$138.02K103,000
Jun 04, 2024Braunstein Scott-Buy----
Jun 04, 2024Fischer Laurent-Buy----
May 20, 2024Brand Florianofficer See RemarksS-SaleSell151,303$1.92$290.50K328,697
Apr 17, 2024Apeiron Investment Group Ltd.10 percent owner-J-OtherBuy147,950--147,950
Apr 17, 2024Apeiron Investment Group Ltd.10 percent owner-J-OtherSell147,950---
Apr 04, 2024Johnson Anne Nagengastofficer Chief Financial OfficerS-SaleSell27,410$1.85$50.71K73,590
Apr 04, 2024Rao Srinivasofficer See RemarksS-SaleSell61,640$1.85$114.03K113,360
Apr 04, 2024Kirpekar Sahilofficer Chief Business OfficerS-SaleSell35,801$1.85$66.23K64,199
Mar 15, 2024Johnson Anne Nagengastofficer Chief Financial OfficerA-AwardBuy550,000$1.84$1.01M550,000
Mar 15, 2024Johnson Anne Nagengastofficer Chief Financial OfficerM-ExemptBuy100,000--101,000
Mar 15, 2024Johnson Anne Nagengastofficer Chief Financial OfficerM-ExemptSell100,000--100,000
Mar 15, 2024Kirpekar Sahilofficer Chief Business OfficerA-AwardBuy550,000$1.84$1.01M550,000
Mar 15, 2024Kirpekar Sahilofficer Chief Business OfficerM-ExemptSell100,000--100,000

The last insider sell of Atai Life Sciences's stock was made by Brand Florian on May 20 2024, selling 151,303 shares at $1.92 per share (valued at $290.50K).

Atai Life Sciences Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 202485160.00%
Q1 202484200.00%
Q4 20231--
Q3 20231--
Q2 20236785.71%
Q1 202312--
Q4 20221--
Q3 2022-1-
Q2 202217--
Q1 202251500.00%
Q4 20212--
Q3 20217--
Q2 2021112550.00%

8 total buy trades, and 5 total sell trades (buy/sell ratio of 1.60%) were made by Atai Life Sciences's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-4-
Q1 2024---
Q4 20231--
Q3 20231--
Q2 2023---
Q1 20232--
Q4 2022---
Q3 2022---
Q2 20229--
Q1 2022---
Q4 2021---
Q3 2021---
Q2 20219--

As of Q2 2024, Insider owners conducted 0 open market buy trades and 4 open market sell trades of Atai Life Sciences's stocks.

Atai Life Sciences Peer Ownership


TickerCompany
EWTXEdgewise Therapeutics, Inc.
GHRSGH Research PLC
BPTHBio-Path Holdings, Inc.
MNMDMind Medicine (MindMed) Inc.
FBIOFortress Biotech, Inc.
SEELSeelos Therapeutics, Inc.
VCNXVaccinex, Inc.
ITOSiTeos Therapeutics, Inc.
MOLNMolecular Partners AG
OPTOpthea Limited
ELYMEliem Therapeutics, Inc.

ATAI Ownership FAQ


Atai Life Sciences is owned by institutional shareholders (7.51%), insiders (10.01%), and public (82.48%). The largest institutional shareholder of Atai Life Sciences is WALLEYE CAPITAL LLC (1.74% of total shares) and the top mutual fund owner is NEXPOINT FUNDS I (0.02% of total shares).

Atai Life Sciences's major institutional shareholders are WALLEYE CAPITAL LLC, MORGAN STANLEY, BLACKROCK INC., BROWN UNIVERSITY, and TWO SIGMA INVESTMENTS, LP. The top five shareholders own together 5.18% of the company's share outstanding.

As of Jun 2024, there are 88 institutional shareholders of Atai Life Sciences.

WALLEYE CAPITAL LLC owns 2.76M shares of Atai Life Sciences, representing 1.74% of the company's total shares outstanding, valued at $3.67M (as of Jun 2024).

As of Jun 2024, MORGAN STANLEY holds 2.72M shares of Atai Life Sciences (ATAI), compromising 1.71% of the company, valued at $3.62M.

BLACKROCK INC is the third largest holder of Atai Life Sciences. The company owns 1.31M of the company's shares outstanding (worth $1.74M).